Marc S. Goodman

Marc Goodman joined the Advisory Board of Della Parola in July 2021. He has built a successful and distinguished career in the commodities and alternative investment industries, earning a reputation for integrity and entrepreneurial innovation.

Mr. Goodman is also a Managing Director and co-founder of Conyers Group LLC, advising hedge fund managers on business strategy and organization. He serves as an independent Director/Trustee and advisor to BDCs, SPACs, asset management firms and hedge funds. Mr. Goodman began his career at Pasternak, Baum and Co., Inc., a global dealer of cash commodities where he was a Vice President and Director. In 1983, he left to form The Kenmar Group, an independent fund of funds manager where he served as Co-Chief Executive Officer and Co-Chief Investment Officer until the firm was sold in 2014.

Mr. Goodman graduated from the Bernard M. Baruch School of Business of the City University of New York with a BBA degree and an MBA in Finance and Investments. He was awarded an Economics and Finance Department Fellowship during his studies. Mr. Goodman currently serves as the Interim CEO of the Diabetes Research Institute Foundation. He is also a member of its national board. Mr. Goodman is also a founder and Chairman of the Stacy Joy Goodman Memorial Foundation.